Products & SolutionsWho We ServeCase StudiesContact Us
Login
Daily Roundup

Roche plans $50 billion investment in US facilities; IMF trims US growth forecast; Office attendance edges lower

What you need to know to start your day
Global pharmaceutical giant Roche, whose subsidiaries include Genentech in the U.S., plans to expand manufacturing and drug development in at least eight states over the next five years. (Getty Images)
Global pharmaceutical giant Roche, whose subsidiaries include Genentech in the U.S., plans to expand manufacturing and drug development in at least eight states over the next five years. (Getty Images)
CoStar News
April 22, 2025 | 9:10 P.M.

RELATED ARTICLES

Roche plans $50 billion investment in US facilities

This news story is available exclusively to CoStar subscribers.

Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.

This news story is available exclusively to CoStar subscribers.

Ready to Learn More?

Sign Up For a Personalized Demo.

Sign Up For a Demo To Learn More.

Explore CoStar

Already A Subscriber? Sign In

Follow us on Social Media

IN THIS ARTICLE

  • Companies
    • Roche

      Professional, Scientific, and Technical Services

    • Genentech

      Professional, Scientific, and Technical Services

Get In Touch
888-226-7404

Request Demo
Products & Solutions
Additional Solutions
Social
© 2025 CoStar Group